Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
CNY 10.16
(0.1%)
CNY 10.16
(0.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 863.95 Million CNY | -20.12% |
| 2022 | 1.02 Billion CNY | 9.47% |
| 2021 | 946.88 Million CNY | 8.93% |
| 2020 | 865.85 Million CNY | 12.53% |
| 2019 | 744.44 Million CNY | 15.84% |
| 2018 | 645.81 Million CNY | 42.69% |
| 2017 | 432.72 Million CNY | 39.71% |
| 2016 | 313.68 Million CNY | 7.5% |
| 2015 | 282.23 Million CNY | 30.14% |
| 2014 | 220.59 Million CNY | 18.66% |
| 2013 | 185.57 Million CNY | -22.44% |
| 2012 | 238.6 Million CNY | 4.54% |
| 2011 | 232.82 Million CNY | 13.76% |
| 2010 | 190.23 Million CNY | 6.8% |
| 2009 | 186.99 Million CNY | 13.32% |
| 2008 | 166.24 Million CNY | 29.06% |
| 2007 | 137.76 Million CNY | 10.69% |
| 2006 | 115.27 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 221.03 Million CNY | -20.82% |
| 2024 Q1 | 188.65 Million CNY | 30.65% |
| 2024 Q2 | 253.8 Million CNY | 20.97% |
| 2023 Q4 | 144.67 Million CNY | -22.98% |
| 2023 Q1 | 164.83 Million CNY | 17.39% |
| 2023 Q3 | 187.84 Million CNY | -18.03% |
| 2023 FY | - CNY | -20.12% |
| 2023 Q2 | 229.16 Million CNY | 39.03% |
| 2022 FY | - CNY | 9.47% |
| 2022 Q4 | 140.41 Million CNY | -42.98% |
| 2022 Q3 | 246.28 Million CNY | -13.12% |
| 2022 Q2 | 283.49 Million CNY | 79.65% |
| 2022 Q1 | 157.8 Million CNY | 6.09% |
| 2021 Q1 | 151.61 Million CNY | -4.26% |
| 2021 Q2 | 226.21 Million CNY | 49.21% |
| 2021 Q3 | 216.58 Million CNY | -4.26% |
| 2021 Q4 | 148.74 Million CNY | -31.32% |
| 2021 FY | - CNY | 8.93% |
| 2020 Q2 | 209.9 Million CNY | 134.94% |
| 2020 FY | - CNY | 12.53% |
| 2020 Q1 | 89.34 Million CNY | -44.26% |
| 2020 Q3 | 221.46 Million CNY | 5.51% |
| 2020 Q4 | 158.36 Million CNY | -28.49% |
| 2019 Q4 | 160.29 Million CNY | -2.11% |
| 2019 FY | - CNY | 15.84% |
| 2019 Q1 | 115.5 Million CNY | -20.29% |
| 2019 Q3 | 163.75 Million CNY | -12.05% |
| 2019 Q2 | 186.19 Million CNY | 61.2% |
| 2018 Q3 | 146.17 Million CNY | 15.51% |
| 2018 FY | - CNY | 42.69% |
| 2018 Q1 | 112.76 Million CNY | 36.23% |
| 2018 Q2 | 126.54 Million CNY | 12.23% |
| 2018 Q4 | 144.91 Million CNY | -0.86% |
| 2017 FY | - CNY | 39.71% |
| 2017 Q4 | 82.77 Million CNY | -18.22% |
| 2017 Q2 | 107.69 Million CNY | 168.85% |
| 2017 Q3 | 101.21 Million CNY | -6.01% |
| 2017 Q1 | 40.05 Million CNY | -7.06% |
| 2016 FY | - CNY | 7.5% |
| 2016 Q4 | 43.1 Million CNY | -37.38% |
| 2016 Q3 | 68.83 Million CNY | -8.82% |
| 2016 Q2 | 75.49 Million CNY | 106.22% |
| 2016 Q1 | 36.6 Million CNY | -38.48% |
| 2015 Q4 | 59.5 Million CNY | 12.36% |
| 2015 Q3 | 52.95 Million CNY | 1.69% |
| 2015 Q2 | 52.07 Million CNY | 9.87% |
| 2015 Q1 | 47.39 Million CNY | 12.18% |
| 2015 FY | - CNY | 30.14% |
| 2014 Q3 | 39.17 Million CNY | 53.33% |
| 2014 FY | - CNY | 18.66% |
| 2014 Q4 | 42.25 Million CNY | 7.86% |
| 2014 Q2 | 25.54 Million CNY | -41.28% |
| 2014 Q1 | 43.5 Million CNY | 272.68% |
| 2013 Q4 | 11.67 Million CNY | -47.42% |
| 2013 FY | - CNY | -22.44% |
| 2013 Q2 | 43.19 Million CNY | -16.09% |
| 2013 Q3 | 22.2 Million CNY | -48.59% |
| 2013 Q1 | 51.47 Million CNY | 26.26% |
| 2012 Q2 | 62.1 Million CNY | 25.44% |
| 2012 Q4 | 40.76 Million CNY | -34.17% |
| 2012 FY | - CNY | 4.54% |
| 2012 Q1 | 49.51 Million CNY | -29.76% |
| 2012 Q3 | 61.93 Million CNY | -0.29% |
| 2011 Q2 | 49.16 Million CNY | 36.43% |
| 2011 Q4 | 70.49 Million CNY | 12.21% |
| 2011 Q3 | 62.82 Million CNY | 27.77% |
| 2011 FY | - CNY | 13.76% |
| 2011 Q1 | 36.04 Million CNY | -19.66% |
| 2010 Q4 | 44.86 Million CNY | -11.75% |
| 2010 Q1 | 37.59 Million CNY | -34.77% |
| 2010 Q2 | 49.69 Million CNY | 32.18% |
| 2010 FY | - CNY | 6.8% |
| 2010 Q3 | 50.83 Million CNY | 2.29% |
| 2009 Q3 | 41.45 Million CNY | 13.25% |
| 2009 Q1 | 33.06 Million CNY | 26.62% |
| 2009 FY | - CNY | 13.32% |
| 2009 Q2 | 36.6 Million CNY | 10.69% |
| 2009 Q4 | 57.64 Million CNY | 39.05% |
| 2008 Q3 | 33.33 Million CNY | 0.0% |
| 2008 Q4 | 26.11 Million CNY | -21.67% |
| 2008 FY | - CNY | 29.06% |
| 2007 FY | - CNY | 10.69% |
| 2006 FY | - CNY | 0.0% |